(0.11%) 5 254.35 points
(0.12%) 39 807 points
(-0.12%) 16 379 points
(-0.07%) $83.11
(-0.62%) $1.752
(0.73%) $2 254.80
(0.74%) $25.10
(0.21%) $923.00
(-0.03%) $0.926
(-0.09%) $10.83
(-0.10%) $0.791
(-0.21%) $92.38
Live Chart Being Loaded With Signals
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases...
Stats | |
---|---|
Today's Volume | 56 955.00 |
Average Volume | 73 414.00 |
Market Cap | 147.82M |
EPS | $-0.240 ( 2023-11-13 ) |
Next earnings date | ( $-0.160 ) 2024-04-04 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -3.14 |
ATR14 | $0.0100 (0.42%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-01 | Lewis Joel | Sell | 152 584 | Common Stock |
2023-12-07 | Carson Benjamin Sr | Sell | 100 000 | Common Stock Options |
2024-01-24 | Zordani Richard A. Jr. | Buy | 50 000 | Stock Option (right to buy) |
2024-01-24 | Uihlein Richard E | Buy | 23 256 | Common Stock |
2024-01-24 | Uihlein Richard E | Buy | 50 000 | Stock Option (right to buy) |
INSIDER POWER |
---|
24.86 |
Last 98 transactions |
Buy: 4 274 677 | Sell: 2 394 317 |
Volume Correlation
Galectin Therapeutics Inc Correlation
10 Most Positive Correlations | |
---|---|
BRACU | 0.946 |
KIN | 0.945 |
ALGM | 0.929 |
ACVA | 0.929 |
NCAC | 0.925 |
CLBT | 0.921 |
PEGA | 0.92 |
NSIT | 0.92 |
AMYT | 0.919 |
SRRA | 0.919 |
10 Most Negative Correlations | |
---|---|
DCRC | -0.928 |
AHPI | -0.923 |
IMV | -0.922 |
NCBS | -0.921 |
TENX | -0.92 |
LAWS | -0.919 |
CFMS | -0.919 |
TSHA | -0.918 |
VWE | -0.917 |
SGLB | -0.914 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Galectin Therapeutics Inc Correlation - Currency/Commodity
Galectin Therapeutics Inc Financials
Annual | 2022 |
Revenue: | $0 |
Gross Profit: | $-32 000.00 (0.00 %) |
EPS: | $-0.660 |
Q3 | 2023 |
Revenue: | $0 |
Gross Profit: | $-8 000.00 (0.00 %) |
EPS: | $-0.170 |
Q2 | 2023 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-0.150 |
Q1 | 2023 |
Revenue: | $0 |
Gross Profit: | $-32 000.00 (0.00 %) |
EPS: | $-0.210 |
Financial Reports:
No articles found.
Galectin Therapeutics Inc
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial for the treatment of liver fibrosis associated with fatty liver disease and non-alcoholic steatohepatitis cirrhosis, as well as for the treatment of cancer. It also engages in developing GM-CT-01, which is in pre-clinical development stage for the treatment of cardiac and vascular fibrosis, as well as focuses on developing belapectin for the treatment of psoriasis, and lung and kidney fibrosis. The company, through its Galectin Sciences, LLC, which is a collaborative joint venture co-owned by SBH Sciences, Inc., to research and development of small organic molecule inhibitors of galectin-3 for oral administration. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics, Inc. in May 2011. Galectin Therapeutics Inc. was founded in 2000 and is based in Norcross, Georgia.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators